A 1064 nm Nd:YAG laser is deployed through a flexible bare quartz fiber to place thermal energy close to deep vascular targets while limiting exposure to the surface. For mucosal or deep exophytic lesions, the fiber is generally used in a non-contact or minimally invasive fashion with repeated short pulses or controlled continuous-wave delivery, producing progressive blanching and vessel coagulation. For epifascial vessels, the fiber is advanced through an indwelling catheter, typically under imaging or other procedural guidance, and energy is delivered along the vessel or perivascular tract while protecting the skin and fascia.
The essential principle is controlled, localized heating rather than prolonged heating at one point. Fiber movement, conservative energy delivery, cooling or saline flushing where appropriate, and continuous assessment of tissue response are required because 1064 nm energy penetrates deeply and can injure structures beyond the target.
How the Fiber-Based System Works
Deep thermal penetration
The 1064 nm wavelength penetrates several millimeters into tissue, commonly approximately 4–6 mm, and can reach deeper, larger-caliber, or slow-flow vascular structures that superficial vascular lasers may not adequately treat.
Hemoglobin absorbs the delivered energy more strongly than much of the surrounding connective or adipose tissue. The resulting heat causes endothelial injury, thrombus formation, vessel contraction, and eventual vascular occlusion.
Bare-fiber energy delivery
A typical bare fiber has a flexible quartz tip and may have a core diameter of approximately 600 µm. It can be passed through a catheter to reach a confined mucosal, intracavitary, interstitial, or epifascial target.
The fiber is not treated as a fixed heating probe. It is repositioned or moved across multiple passes so that thermal zones overlap in a controlled manner without creating a single excessively hot region.
Deployment for Mucosal and Deep Exophytic Lesions
Positioning without direct contact
For mucosal lesions involving sites such as the lip, tongue, or buccal mucosa, the fiber is directed toward the lesion and used in a non-contact or minimally invasive mode. Avoiding sustained direct contact reduces the risk of fiber-tip adherence, carbonization, and uncontrolled surface heating.
The operator advances treatment step by step, observing blanching and other tissue responses before proceeding to adjacent areas. The goal is progressive vessel closure rather than immediate destruction of the entire lesion.
Repeat-pulse treatment
The primary reference describes repeat-pulse operation at approximately 20 W with 0.2-second pulses for targeted blanching and staged coagulation. Other protocols may use different pulse durations, including longer subsecond pulses, so these values should be treated as protocol-specific rather than universal settings.
The appropriate parameters depend on lesion depth, vessel caliber, blood flow, tissue thickness, treatment geometry, and the manufacturer’s validated clinical protocol.
Continuous-wave treatment
Continuous-wave operation may be used at up to approximately 30 W in selected mucosal or deep exophytic applications. Because continuous delivery can accumulate heat rapidly, it requires deliberate fiber movement, short exposure at each location, and frequent reassessment of the mucosa.
The operator should stop or reduce delivery when the intended blanching response is achieved rather than continuing until surface charring or tissue contraction becomes pronounced.
Deployment for Epifascial Vascular Structures
Catheter-guided access
For epifascial vascular shrinkage, the bare fiber is guided through an indwelling catheter positioned along or adjacent to the target vascular structure. Ultrasound or another appropriate guidance method can help confirm the catheter path and its relationship to skin, fascia, nerves, and other critical anatomy.
The fiber is then used to deliver energy locally along the vascular tract. This approach concentrates heating near the vessel while avoiding broad transcutaneous irradiation.
Controlled continuous-wave delivery
The reference describes approximately 5 W in continuous-wave mode for catheter-based epifascial treatment. It also describes approximately 8 W when continuous 0.9% sodium chloride rinsing is used, allowing fluid to remove heat and reduce thermal strain on the overlying skin and fascia.
The intended response is localized perivascular inflammation and controlled vascular occlusion, sometimes described as localized perivasculitis, without producing dermal necrosis.
Saline flushing in larger or ectatic vessels
When the fiber is positioned intraluminally in a large ectatic venous or arteriovenous malformation, continuous saline flushing may be used to reduce blood carbonization at the fiber tip.
The flushing system must be compatible with the catheter and procedure, and the operator must monitor for fluid-related complications, loss of visualization, displacement, and inadequate energy coupling.
How Treatment Response Is Controlled
Fiber motion and staged passes
The fiber tip should remain in continuous motion or be repositioned between brief applications. Multiple passes from different directions distribute heat and reduce the chance of an unpredictable high-temperature zone.
A fixed fiber tip can create focal carbonization, perforation, excessive necrosis, or injury to adjacent nerves and fascia.
Tissue-response monitoring
Blanching, vessel collapse, changes in resistance, temperature behavior, and imaging findings can help determine whether the intended response has occurred. Treatment should be staged when the target is deep, extensive, or close to sensitive anatomy.
A visible surface response does not reliably indicate the full depth of the thermal zone, so the operator must account for subsurface heat diffusion after energy delivery stops.
Protection of adjacent structures
The treatment plan must account for nearby motor nerves, skin, mucosa, fascia, teeth, bone, and major vessels. High-risk regions, including spaces containing major nerves such as the facial nerve in the parotid region, require particular caution or may be unsuitable for this technique.
Anesthesia and patient communication are also important because pain can signal excessive heating or unintended energy delivery, although analgesia may reduce the reliability of pain as a warning sign.
Understanding the Trade-offs
Depth versus collateral injury
The main advantage of 1064 nm delivery is depth. The same penetration that permits treatment of deep vessels also creates a risk of nonspecific heating in tissue beyond the vessel.
Potential complications include dermal or mucosal necrosis, scarring, nerve injury, ulceration, bleeding, and damage to surrounding fascia.
Power and pulse duration are not interchangeable
A lower power delivered for longer may produce a similar total energy to a higher power delivered briefly, but the tissue response may differ because heat diffusion and peak temperature are different.
Therefore, settings cannot be selected by total joules alone. Pulse structure, fiber motion, contact geometry, blood flow, cooling, and tissue thickness all affect the thermal result.
Conflicting parameter ranges require protocol discipline
The supplied references contain different pulse-duration ranges, including millisecond long-pulse protocols, subsecond repeat-pulse protocols, and continuous-wave techniques. These describe different clinical configurations and should not be combined into a single generic prescription.
The treating team should follow the device’s instructions for use, the validated indication-specific protocol, and local specialist guidance rather than transferring settings from transcutaneous treatment to bare-fiber mucosal or catheter-based treatment.
Cooling has a specific role
Surface cooling can protect the epidermis during transcutaneous treatment, but it does not by itself eliminate the risk of deep injury from an interstitial or epifascial fiber.
For intraluminal use, saline flushing serves a different purpose: it helps manage heat and prevent carbonization at the fiber tip. Neither method substitutes for correct positioning and controlled energy delivery.
How to Apply This to the Clinical Goal
A bare-fiber Nd:YAG procedure should be performed only by appropriately trained clinicians using suitable imaging, monitoring, protective equipment, and a validated protocol.
- If your primary focus is a mucosal or deep exophytic lesion: Use a flexible bare fiber in non-contact or minimally invasive mode, apply staged repeat pulses or carefully controlled continuous-wave energy, and advance only after confirming the intended blanching response.
- If your primary focus is an epifascial vascular structure: Place the fiber through a catheter under appropriate guidance and use controlled low-power continuous-wave delivery while protecting the skin, fascia, and nearby nerves.
- If your primary focus is a large ectatic or intraluminal malformation: Consider continuous saline flushing at the fiber tip to limit carbonization and manage local heat, with monitoring for catheter and fluid-related complications.
- If your primary focus is minimizing collateral damage: Keep the fiber moving or reposition it between applications, avoid prolonged fixed exposure, and treat high-risk nerve-containing anatomical spaces with particular caution.
- If your primary focus is selecting treatment parameters: Treat published wattage and pulse examples as protocol-specific reference points, not as a universal treatment prescription.
Safe deployment depends on matching the fiber position, energy pattern, thermal management, and anatomical risk to the specific vascular target.
Summary Table:
| Deployment Method | Application | Typical Parameters | Key Considerations |
|---|---|---|---|
| Non-contact/mucosal | Mucosal or deep exophytic lesions | 20 W, 0.2 s pulses or CW up to 30 W | Avoid contact, monitor blanching, staged passes |
| Catheter-guided epifascial | Epifascial vessels | CW ~5 W (up to 8 W with saline flush) | Use imaging guidance, protect skin/fascia |
| Intraluminal flush | Large ectatic vessels | Saline flushing during delivery | Prevent carbonization, monitor fluid complications |
Achieve safe and effective vascular treatments with BELIS's advanced Nd:YAG laser systems. As a leading manufacturer of professional aesthetic equipment, we provide high-quality devices and comprehensive training to ensure optimal outcomes. Contact our experts today to learn more about our laser solutions. Get in touch with us for a consultation and elevate your practice.
Related Products
- Tri Laser Diode Hair Removal Machine Professional Beauty Equipment
- 808nm Diode Laser Hair Removal Machine 755+808+1064nm Mixed Wavelength Professional Equipment
- Q Switch Nd Yag Laser Machine Tattoo Removal Nd Yag Machine
- Clinic Use IPL and SHR Hair Removal Machine with Nd Yag Laser Tattoo Removal
- Clinic Use IPL SHR ND YAG Laser Hair Removal RF Skin Tightening Machine
People Also Ask
- How can aesthetic practitioners prevent side effects like paradoxical hair regrowth and thermal burns when performing diode laser hair removal on dark skin? Master safe protocols for Fitzpatrick IV–VI skin.
- How do demographic trends in non-surgical procedures like laser hair removal compare to surgical aesthetics, and how should clinics leverage professional diode laser hair removal equipment to meet this demand?
- Why is monitoring the revenue rate per hour per physician essential when deciding to invest in high-throughput aesthetic technology like diode hair removal lasers or multi-applicator body sculpting machines? Optimize your practice's profitability
- What are the primary differences in mechanism and pigment dependency between standard laser hair removal devices (Alexandrite, Diode, Nd:YAG) and photosensitizer-assisted light therapies? Discover expert insights and tailored solutions
- Why is the Anagen phase the primary target for laser hair removal machines? Unlock the science for optimal results